- vaccine: BNT162b2
  dosage: 1.0
  infection: ''
  num_ref_name: 27
  num_fold: 4093
  S: 3167
  I: 742
  R: 184
  median_fold: 2.0
  percent: 3.0
  priority: 1
- vaccine: BNT162b2
  dosage: 1.0
  infection: infected
  num_ref_name: 24
  num_fold: 1273
  S: 891
  I: 346
  R: 36
  median_fold: 3.0
  percent: 0.94
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 183
  num_fold: 22376
  S: 15398
  I: 5132
  R: 1846
  median_fold: 2.9
  percent: 16.0
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 49
  num_fold: 3529
  S: 2184
  I: 1155
  R: 190
  median_fold: 3.5
  percent: 2.6
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 81
  num_fold: 7594
  S: 4103
  I: 2834
  R: 657
  median_fold: 4.3
  percent: 5.6
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: infected
  num_ref_name: 19
  num_fold: 1871
  S: 1064
  I: 587
  R: 220
  median_fold: 3.7
  percent: 1.4
  priority: 1
- vaccine: BNT162b2
  dosage: 4.0
  infection: ''
  num_ref_name: 4
  num_fold: 298
  S: 3
  I: 110
  R: 185
  median_fold: 32.0
  percent: 0.22
  priority: 1
- vaccine: BNT162b2
  dosage: 4.0
  infection: infected
  num_ref_name: 3
  num_fold: 268
  S: 40
  I: 126
  R: 102
  median_fold: 16.0
  percent: 0.2
  priority: 1
- vaccine: mRNA-1273
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 155
  S: 131
  I: 24
  R: 0
  median_fold: 1.5
  percent: 0.11
  priority: 2
- vaccine: mRNA-1273
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 7
  I: 4
  R: 3
  median_fold: 5.3
  percent: 0.01
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 68
  num_fold: 9298
  S: 6211
  I: 2538
  R: 549
  median_fold: 3.9
  percent: 6.9
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: infected
  num_ref_name: 9
  num_fold: 393
  S: 268
  I: 101
  R: 24
  median_fold: 3.1
  percent: 0.29
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 22
  num_fold: 4433
  S: 2904
  I: 1449
  R: 80
  median_fold: 4.5
  percent: 3.3
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: infected
  num_ref_name: 5
  num_fold: 472
  S: 231
  I: 234
  R: 7
  median_fold: 5.1
  percent: 0.35
  priority: 2
- vaccine: mRNA-1273
  dosage: 4.0
  infection: ''
  num_ref_name: 2
  num_fold: 526
  S: 260
  I: 263
  R: 3
  median_fold: 12.0
  percent: 0.39
  priority: 2
- vaccine: mRNA-1273
  dosage: 4.0
  infection: infected
  num_ref_name: 2
  num_fold: 295
  S: 114
  I: 153
  R: 28
  median_fold: 5.5
  percent: 0.22
  priority: 2
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: ''
  num_ref_name: 22
  num_fold: 1510
  S: 1079
  I: 363
  R: 68
  median_fold: 2.9
  percent: 1.1
  priority: 3
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: infected
  num_ref_name: 8
  num_fold: 198
  S: 141
  I: 48
  R: 9
  median_fold: 2.6
  percent: 0.15
  priority: 3
- vaccine: Ad26.COV2.S
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 558
  S: 289
  I: 253
  R: 16
  median_fold: 4.6
  percent: 0.41
  priority: 3
- vaccine: AZD1222
  dosage: 1.0
  infection: ''
  num_ref_name: 10
  num_fold: 1752
  S: 689
  I: 559
  R: 504
  median_fold: 6.0
  percent: 1.3
  priority: 4
- vaccine: AZD1222
  dosage: 1.0
  infection: infected
  num_ref_name: 4
  num_fold: 680
  S: 587
  I: 93
  R: 0
  median_fold: 3.3
  percent: 0.5
  priority: 4
- vaccine: AZD1222
  dosage: 2.0
  infection: ''
  num_ref_name: 40
  num_fold: 3599
  S: 1953
  I: 1044
  R: 602
  median_fold: 4.4
  percent: 2.7
  priority: 4
- vaccine: AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 14
  num_fold: 1847
  S: 1212
  I: 519
  R: 116
  median_fold: 3.6
  percent: 1.4
  priority: 4
- vaccine: AZD1222
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 990
  S: 211
  I: 779
  R: 0
  median_fold: 6.8
  percent: 0.73
  priority: 4
- vaccine: BBIBP-CorV
  dosage: 2.0
  infection: ''
  num_ref_name: 12
  num_fold: 3147
  S: 1933
  I: 879
  R: 335
  median_fold: 3.4
  percent: 2.3
  priority: 6
- vaccine: BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 552
  S: 113
  I: 438
  R: 1
  median_fold: 20.0
  percent: 0.41
  priority: 6
- vaccine: BBV152
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 477
  S: 449
  I: 7
  R: 21
  median_fold: 1.4
  percent: 0.35
  priority: 7
- vaccine: BBV152
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 170
  S: 151
  I: 0
  R: 19
  median_fold: 2.4
  percent: 0.13
  priority: 7
- vaccine: CoronaVac
  dosage: 1.0
  infection: ''
  num_ref_name: 3
  num_fold: 220
  S: 220
  I: 0
  R: 0
  median_fold: 1.5
  percent: 0.16
  priority: 8
- vaccine: CoronaVac
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 390
  S: 242
  I: 148
  R: 0
  median_fold: 3.3
  percent: 0.29
  priority: 8
- vaccine: CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 21
  num_fold: 2376
  S: 1600
  I: 717
  R: 59
  median_fold: 3.1
  percent: 1.8
  priority: 8
- vaccine: CoronaVac
  dosage: 2.0
  infection: infected
  num_ref_name: 7
  num_fold: 250
  S: 136
  I: 74
  R: 40
  median_fold: 4.7
  percent: 0.18
  priority: 8
- vaccine: CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 15
  num_fold: 4672
  S: 848
  I: 2784
  R: 1040
  median_fold: 14.0
  percent: 3.4
  priority: 8
- vaccine: CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 6
  num_fold: 11764
  S: 2402
  I: 5492
  R: 3870
  median_fold: 15.0
  percent: 8.7
  priority: 8
- vaccine: NVX-CoV2373
  dosage: 2.0
  infection: ''
  num_ref_name: 4
  num_fold: 275
  S: 110
  I: 103
  R: 62
  median_fold: 8.1
  percent: 0.2
  priority: 9
- vaccine: NVX-CoV2373
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 212
  S: 48
  I: 164
  R: 0
  median_fold: 8.2
  percent: 0.16
  priority: 9
- vaccine: ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 7
  num_fold: 716
  S: 210
  I: 461
  R: 45
  median_fold: 8.1
  percent: 0.53
  priority: 10
- vaccine: mRNA-1273 + mRNA-1273.211
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 4882
  S: 4850
  I: 32
  R: 0
  median_fold: 2.3
  percent: 3.6
  priority: 24
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 423
  S: 170
  I: 250
  R: 3
  median_fold: 7.4
  percent: 0.31
  priority: 34
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: infected
  num_ref_name: 4
  num_fold: 293
  S: 242
  I: 36
  R: 15
  median_fold: 2.8
  percent: 0.22
  priority: 34
- vaccine: mRNA-monovalent
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 50
  S: 24
  I: 26
  R: 0
  median_fold: 5.4
  percent: 0.037
  priority: 47
- vaccine: mRNA-monovalent
  dosage: 3.0
  infection: ''
  num_ref_name: 7
  num_fold: 525
  S: 150
  I: 184
  R: 191
  median_fold: 14.0
  percent: 0.39
  priority: 47
- vaccine: mRNA-monovalent
  dosage: 3.0
  infection: infected
  num_ref_name: 7
  num_fold: 1199
  S: 546
  I: 249
  R: 404
  median_fold: 6.7
  percent: 0.88
  priority: 47
- vaccine: mRNA-monovalent
  dosage: 4.0
  infection: ''
  num_ref_name: 4
  num_fold: 528
  S: 38
  I: 245
  R: 245
  median_fold: 15.0
  percent: 0.39
  priority: 47
- vaccine: mRNA-monovalent
  dosage: 4.0
  infection: infected
  num_ref_name: 2
  num_fold: 260
  S: 120
  I: 70
  R: 70
  median_fold: 7.6
  percent: 0.19
  priority: 47
- vaccine: mRNA-bivalent + mRNA-monovalent
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 138
  S: 54
  I: 68
  R: 16
  median_fold: 6.9
  percent: 0.1
  priority: 48
- vaccine: mRNA-bivalent + mRNA-monovalent
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 110
  S: 44
  I: 55
  R: 11
  median_fold: 8.0
  percent: 0.081
  priority: 48
- vaccine: mRNA-bivalent + mRNA-monovalent
  dosage: 4.0
  infection: ''
  num_ref_name: 4
  num_fold: 522
  S: 70
  I: 259
  R: 193
  median_fold: 23.0
  percent: 0.38
  priority: 48
- vaccine: mRNA-bivalent + mRNA-monovalent
  dosage: 4.0
  infection: infected
  num_ref_name: 2
  num_fold: 138
  S: 18
  I: 64
  R: 56
  median_fold: 17.0
  percent: 0.1
  priority: 48
- vaccine: Convidecia
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 215
  S: 215
  I: 0
  R: 0
  median_fold: 1.4
  percent: 0.16
  priority: 50
- vaccine: Sputnik V
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 592
  S: 408
  I: 142
  R: 42
  median_fold: 4.0
  percent: 0.44
  priority: 52
- vaccine: AZD1222 + Sputnik V
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 104
  S: 28
  I: 76
  R: 0
  median_fold: 9.5
  percent: 0.077
  priority: 54
- vaccine: KCONVAC
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 251
  S: 241
  I: 10
  R: 0
  median_fold: 1.2
  percent: 0.18
  priority: 56
- vaccine: CoronaVac or BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 588
  S: 541
  I: 47
  R: 0
  median_fold: 4.2
  percent: 0.43
  priority: 57
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 225
  S: 98
  I: 107
  R: 20
  median_fold: 7.5
  percent: 0.17
  priority: 64
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 6
  S: 6
  I: 0
  R: 0
  median_fold: 0.65
  percent: 0.0044
  priority: 64
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 552
  S: 425
  I: 127
  R: 0
  median_fold: 2.6
  percent: 0.41
  priority: 64
- vaccine: Ad26.COV2.S + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 270
  S: 135
  I: 135
  R: 0
  median_fold: 5.4
  percent: 0.2
  priority: 65
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 12
  num_fold: 1792
  S: 511
  I: 457
  R: 824
  median_fold: 12.0
  percent: 1.3
  priority: 68
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 12
  S: 6
  I: 5
  R: 1
  median_fold: 4.9
  percent: 0.0088
  priority: 68
- vaccine: AZD1222 + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 9
  num_fold: 1187
  S: 459
  I: 482
  R: 246
  median_fold: 7.9
  percent: 0.87
  priority: 68
- vaccine: AZD1222 + BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 89
  S: 89
  I: 0
  R: 0
  median_fold: 2.6
  percent: 0.066
  priority: 69
- vaccine: AZD1222 + CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 209
  S: 120
  I: 29
  R: 60
  median_fold: 3.3
  percent: 0.15
  priority: 70
- vaccine: AZD1222 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 125
  S: 125
  I: 0
  R: 0
  median_fold: 0.8
  percent: 0.092
  priority: 70
- vaccine: AZD1222 + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 177
  S: 166
  I: 11
  R: 0
  median_fold: 2.5
  percent: 0.13
  priority: 73
- vaccine: AZD1222 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 680
  S: 560
  I: 120
  R: 0
  median_fold: 1.8
  percent: 0.5
  priority: 73
- vaccine: BBIBP-CorV + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 149
  S: 113
  I: 36
  R: 0
  median_fold: 3.5
  percent: 0.11
  priority: 76
- vaccine: BBIBP-CorV + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 252
  S: 52
  I: 182
  R: 18
  median_fold: 7.8
  percent: 0.19
  priority: 78
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 11
  num_fold: 743
  S: 466
  I: 271
  R: 6
  median_fold: 4.6
  percent: 0.55
  priority: 80
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 92
  S: 68
  I: 24
  R: 0
  median_fold: 2.0
  percent: 0.068
  priority: 80
- vaccine: CoronaVac + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 98
  S: 98
  I: 0
  R: 0
  median_fold: 4.2
  percent: 0.072
  priority: 88
- vaccine: Unknown vaccine
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 204
  S: 85
  I: 102
  R: 17
  median_fold: 8.0
  percent: 0.15
  priority: 95
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 528
  S: 320
  I: 177
  R: 31
  median_fold: 3.2
  percent: 0.39
  priority: 95
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: infected
  num_ref_name: 11
  num_fold: 1214
  S: 889
  I: 264
  R: 61
  median_fold: 3.0
  percent: 0.89
  priority: 95
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 78
  S: 32
  I: 43
  R: 3
  median_fold: 7.2
  percent: 0.057
  priority: 95
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: infected
  num_ref_name: 8
  num_fold: 830
  S: 574
  I: 242
  R: 14
  median_fold: 3.3
  percent: 0.61
  priority: 95
